ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

QNCX Quince Therapeutics Inc

0.9851
0.0251 (2.61%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Quince Therapeutics Inc QNCX 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.0251 2.61% 0.9851 09:00:00
개장가 저가 고가 종가 전일 종가
0.92 0.92 0.99 0.9851 0.96
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/04/202420:00BWQuince Therapeutics Provides Business Update and Reports..
22/02/202421:00BWQuince Therapeutics Launches Scientific Advisory Board
16/02/202406:00EDGAR2Form 8-K - Current report
15/02/202421:00BWQuince Therapeutics Appoints Former Reata Pharmaceuticals..
08/02/202406:05BWQuince Therapeutics to Present at Oppenheimer 34th Annual..
03/02/202407:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:01EDGAR2Form 8-K/A - Current report: [Amend]
05/01/202406:05BWQuince Therapeutics to Participate at Investor Events in..
04/01/202406:02EDGAR2Form 8-K - Current report
23/12/202306:08EDGAR2Form 8-K - Current report
15/12/202308:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202306:06EDGAR2Form 8-K - Current report
08/12/202308:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202303:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202306:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202308:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202308:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
24/10/202305:05EDGAR2Form 8-K - Current report
23/10/202320:00BWQuince Therapeutics Completes Acquisition of EryDel S.p.A.
29/09/202305:53DJNQuince Therapeutics to Advance Study of EryDex as FDA Lifts..
29/09/202305:05BWU.S. FDA Partial Clinical Hold Lifted on IND for EryDel’s..
06/09/202320:18EDGAR2Form 8-K - Current report
06/09/202320:00BWQuince Therapeutics Appoints Dr. Charles S. Ryan as..
01/09/202307:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/08/202307:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202306:05EDGAR2Form 8-K - Current report
11/08/202305:05BWQuince Therapeutics to Present at Sidoti Virtual Investor..
10/08/202307:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202307:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/08/202305:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/07/202306:56BWQuince Therapeutics rileva EryDel SpA e il suo asset di fase..
24/07/202320:16EDGAR2Form 8-K - Current report
24/07/202320:00BWQuince Therapeutics to Acquire EryDel SpA and its Phase 3..

최근 히스토리

Delayed Upgrade Clock